So far, as of 11:00am today, 12/19, we are seeing follow through on yesterdays move to the upside with increasing volume. The stock's volume is being assisted by today's "triple- witch" options and futures expirations. WebMD is now enjoying an increase in both the 20 day and 50 day moving averages, ending the previous declines each day. Also, the 200 day moving average is very close to ending its decline and very soon will reflect increases in its daily average. The other ingredients for continued moves to the upside will be the issuance of executive stock options and the end of the 4th qtr. I expect the Market Edge Second Opinion Weekly to change its position from Neutral to Buy on Monday, 12/23.
The volume in the After Hours trading was 161,934. 2 blocks of 75,630 shares traded. Total volume today was 601,200 shares. Let's see if we have follow through on Friday.
Probably what Wygod wants at this time! After options are issued and they buy back the targeted number of shares in their financial plan, then and only then, will he release any meaningful data, assuming they have something to stimulate interest in the stock !! The jury is out on that point !!
As of 11:30 am, low volume, so no real conviction to the upside, even though we crossed above the 50 day moving average.
Well, we are at the 9th trading day of 10 since I posted the above 12/5/14 Closing Price VS. Closing 50 Day Average and it appears that today 12/18, WebMD will cross its 50 day moving average of $38.25. Given today's early morning futures indices, we will have a strong open for the overall market. Volume on WebMD is what I will be watching to confirm a change in direction to the upside. Also, today is the 1 year anniversary since the last options grants to the key executives, (filing issued on 12/20/13) which, when, and if they are issued, may mark the end of the news silence at WebMD Headquarters. However, I do not expect much of any meaningful announcements until January 2015, Happy Holiday's to all WebMD contributors. Hopefully, 2015 will be a much better year!!
i have so much faith in you aud802009. where did you learn how to spell crystal? i'm sure you predicted the move to 50 as well earlier in the year. this baby moves up and down and like others have noted has been frustrating. have fun with your short. i still like it in this range as a buy. could take a little while to increase but i'm ok with that.
i have no idea now,part of this that the overakll mkt looks weak to me though steve i expect apple to be one of the few winners next year,we saw this a few years ago,when iphone first came out,weak mkt abnd apple exploded.as for wbmd i think we drift around aimlessly for a year
This is the term WebMD CEO David Schlanger used to describe how he felt about 2015 prospects. How should we interpret this language? I, for one, who sat on that side of the table, for many years, would interpret it as follows. Starting with this years high end revenue growth rate of + 13% / $580 million, I believe that the first forecast for 2015, out of the box, come mid February must, at a minimum, be equal to the 2014 high end growth rate of +13%. The next question is, what is the low end of the 2015 Revenue growth rate? My gut tells me it will be 9%. Therefore, I think the first pass at 2015 Revenue will be about $ 630 million to $ 655 million, or a range of + 9% to +13%. Still being conservative, but not reflecting a high end that is below the 2014 +13% growth rate, which I believe they will deliver. Next, the EBITDA number, which should come in at about 30% of Revenue, or a range of between $190 million to $202 million, or +25% to +28%. Finally, the Net Income range will be from $70 million to $80 million, or +92% to +98%. The earnings per share is more difficult to say as I can't predict the fully diluted float, due to buybacks. However, I'll guess it will be 50 million shares, so the earnings per share would be in the range of $1.40 to $1.60 fully diluted. The reason for the high float, fully diluted, is due to the anticipated conversion of the $66.00 notes, totaling 6.2 million shares. The current 2014 fully diluted float already incorporates the $52.00 notes and stands at approx.46 million shares. Therefore, my fully diluted float of 50 million assumes at least 2 million more shares will be bought back in 2015.
Now, as far as the share price next year, I'll let someone else with a crystal ball provide that estimate. LOL
Limp, I think the only answer you will receive, given your understanding of the ying and yang of the WebMD stock, will be, why don't you buy when options are granted and sell into the tender offers as all the WebMD executives do with their vested stock options. Marty is pretty much lawyered up so that he is assured that his operational financial engineering is all legally cleared by the WebMD attorney's..